6 min listen
Science 37 (SNCE) CEO On Stock Beginning Trading On The Nasdaq Today
FromSchwab Network
ratings:
Length:
6 minutes
Released:
Oct 7, 2021
Format:
Podcast episode
Description
Science 37 (SNCE) is an American clinical research company that specializes in Decentralized Clinical Trials. CEO David Coman weighs in on the stock beginning to trade today on the Nasdaq after a SPAC deal with LifeSci Acquisition II Corp. Approximately $235M net cash was received in the deal. How will the stock continue to perform and what is next for the now public company?
Released:
Oct 7, 2021
Format:
Podcast episode
Titles in the series (100)
Historical Look At S&P 500 During Election Years by Schwab Network